Verastem

VSTMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$592.268 M

$6.74 +14.04%

Close of 7 Aug 2026

Revenue

$30.9M

#2886 by revenue

Earnings

-$209.5M

Loss-making

Shares outstanding

90,563,441

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#196ARS PharmaceuticalsSPRY$611.7M
#197AltimmuneALT$599.0M
#198VerastemVSTM$592.3M
#199CorMedixCRMD$583.7M
#200ArvinasARVN$572.1M

Where these numbers come from

Share counts and financials for Verastem are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.